Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Schwabl

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2013
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingThomas Reiberger, Berit Anna Payer, Philipp Schwabl, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Scandinavian Journal of Gastroenterology|May 24, 2017
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varicesBernhard Scheiner, Diego Parada-Rodriguez, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 23, 2025
Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver FailureVlad Taru, Georg Kramer, Benedikt S Hofer, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Plos One|November 5, 2014
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascitesMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
Ultrasound in Medicine & Biology|September 23, 2018
Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral HepatitisTheresa Bucsics, Benjamin Grasl, Arnulf Ferlitsch, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2013
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingThomas Reiberger, Berit Anna Payer, Philipp Schwabl, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Scandinavian Journal of Gastroenterology|May 24, 2017
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varicesBernhard Scheiner, Diego Parada-Rodriguez, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 23, 2025
Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver FailureVlad Taru, Georg Kramer, Benedikt S Hofer, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Plos One|November 5, 2014
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascitesMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
Ultrasound in Medicine & Biology|September 23, 2018
Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral HepatitisTheresa Bucsics, Benjamin Grasl, Arnulf Ferlitsch, et al.
Pageof 15